Data / Form D filings / PALATIN TECHNOLOGIES INC
PALATIN TECHNOLOGIES INC: Form D filing
PALATIN TECHNOLOGIES INC, a pharmaceuticals company in Cranbury, NJ, filed a Form D with the SEC in 2012. The latest, on July 13, 2012, reports $35 million sold of a $35 million offering to 3 investors.
Find out what PALATIN TECHNOLOGIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4B CEDAR BROOK DRIVE, Cranbury, NJ, 08512
- Phone
- (609) 495-2200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 911216
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2012 | New notice | $35,000,000 | $35,000,000 | $0 | 3 | Jul 2, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zola P. Horovitz | Director | |
| Robert I. Taber | Director | |
| Robert K. deVeer | Director | |
| John K. A. Prendergast | Director | |
| Stephen T. Wills | Executive Officer | |
| Perry B. Molinoff | Director | |
| Alan W. Dunton | Director | |
| Joseph Stanley Hull | Director | |
| Carl Spana | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jul 9, 2012 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PALATIN TECHNOLOGIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.